BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18579636)

  • 1. Diabetes after transplantation and sirolimus: what's the connection?
    Pavlakis M; Goldfarb-Rumyantzev AS
    J Am Soc Nephrol; 2008 Jul; 19(7):1255-6. PubMed ID: 18579636
    [No Abstract]   [Full Text] [Related]  

  • 2. Steroid immunosuppression in kidney transplantation: a passing era.
    Schulak JA
    J Surg Res; 2004 Mar; 117(1):154-62. PubMed ID: 15013726
    [No Abstract]   [Full Text] [Related]  

  • 3. Sirolimus for solid organ transplantation in children.
    Gupta P; Kaufman S; Fishbein TM
    Pediatr Transplant; 2005 Jun; 9(3):269-76. PubMed ID: 15910380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ups and downs of sirolimus in kidney transplantation, and the importance of reporting negative findings.
    van Gelder T
    Neth J Med; 2007 Jan; 65(1):3-4. PubMed ID: 17293633
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunosuppression with sirolimus so donor kidneys survive longer].
    MMW Fortschr Med; 2004 Aug; 146(31-32):46-7. PubMed ID: 15529711
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pro- and antitumor effects of the main immunosuppressive drugs used in the clinical practice of transplantation].
    Marchini F
    G Ital Nefrol; 2007; 24(2):171. PubMed ID: 17458835
    [No Abstract]   [Full Text] [Related]  

  • 7. Sirolimus is associated with new-onset diabetes in kidney transplant recipients.
    Johnston O; Rose CL; Webster AC; Gill JS
    J Am Soc Nephrol; 2008 Jul; 19(7):1411-8. PubMed ID: 18385422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of side effects of sirolimus therapy.
    Stallone G; Infante B; Grandaliano G; Gesualdo L
    Transplantation; 2009 Apr; 87(8 Suppl):S23-6. PubMed ID: 19384183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical rejection and sirolimus associated edema in renal allograft recipients.
    Rico J; Cruzado JM; Bestard O; Duarte V; Rama I; Gomà M; Torras J; Grinyó JM
    Transpl Int; 2007 Jul; 20(7):636-9. PubMed ID: 17442067
    [No Abstract]   [Full Text] [Related]  

  • 10. Considerations in sirolimus use in the early and late post-transplant periods.
    Patel SJ; Elliott EN; Knight RJ; Gaber LW; Gaber AO
    Expert Opin Drug Saf; 2009 Jul; 8(4):421-34. PubMed ID: 19522662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?
    Hanto DW; Chudzinski R
    Transplantation; 2009 Jan; 87(2):164-5. PubMed ID: 19155968
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapamune. New tablet combats kidney rejection.
    Nursing; 2002 Apr; 32(4):26. PubMed ID: 11969008
    [No Abstract]   [Full Text] [Related]  

  • 13. [Renal transplantation for diabetic nephropathy].
    Sugitani A; Okabe Y; Hoshinaga K; Kitada H; Doi A; Nishiki T; Tanaka M
    Nihon Jinzo Gakkai Shi; 2008; 50(7):904-10. PubMed ID: 19069148
    [No Abstract]   [Full Text] [Related]  

  • 14. Coping with rejection: immunosuppressants and organ transplantation.
    Woodcock J
    Drug Discov Today; 2005 Jan; 10(1):11-3. PubMed ID: 15676293
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of Sirolimus in five pediatric patients undergoing solid organ transplantation].
    Roque E J; Ríos M G; Vignolo A P; Pinochet V C; Schultz M; Humeres A R; Delucchi A; Rius A M; Hepp K J
    Rev Med Chil; 2008 May; 136(5):631-6. PubMed ID: 18769812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chylous ascites in a renal transplant recipient under sirolimus (rapamycin) treatment.
    Castro G; Freitas C; Beirão I; Rocha G; Henriques AC; Cabrita A
    Transplant Proc; 2008 Jun; 40(5):1756-8. PubMed ID: 18589188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecule of the month. Everolimus.
    Drug News Perspect; 2004 Mar; 17(2):142. PubMed ID: 15098068
    [No Abstract]   [Full Text] [Related]  

  • 18. SDZ RAD. Rapamycin SDZ.
    Drugs R D; 1999 Jan; 1(1):97-9. PubMed ID: 10566000
    [No Abstract]   [Full Text] [Related]  

  • 19. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of variability of sirolimus trough level on chronic allograft nephropathy.
    Wu MJ; Shu KH; Lian JD; Yang CR; Cheng CH; Chen CH
    Transplant Proc; 2008 Sep; 40(7):2202-5. PubMed ID: 18790192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.